Selling And Administration Expenses Lave om Dato
AbbVie USD 3.61B 273M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
J&J USD 5.81B 410M 2023-12
Merck USD 2.75B 272M 2023-12
Moderna USD 470M 28M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
United Therapeutics USD 128.6M 1000K 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Gilead Sciences Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.